Your session is about to expire
← Back to Search
Behavioural Intervention
Active Vibrotactile Coordinated Reset (vCR) for Overactive Bladder
N/A
Waitlist Available
Led By Peter Tass, MD PhD
Research Sponsored by Synergic Medical Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14months
Summary
This trial is testing a special glove that sends gentle vibrations to the fingertips to help Parkinson's disease patients. The goal is to offer a non-invasive alternative to medications and surgeries, which can have severe side effects or risks. The vibrations are believed to help the brain better control movement, potentially reducing symptoms. A wearable tremor suppression glove has been previously demonstrated to manage hand and finger tremor in Parkinson's disease patients.
Eligible Conditions
- Overactive Bladder
- Parkinson's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3
Secondary study objectives
Gait
Kinesia One motor evaluation
Levodopa equivalent daily dose (LEDD)
+8 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active Vibrotactile Coordinated Reset (vCR)Active Control1 Intervention
Participants in this arm will receive active vCR stimulation.
Group II: Sham Vibrotactile Coordinated Reset (vCR)Placebo Group1 Intervention
Participants in this arm will receive sham vCR stimulation.
Find a Location
Who is running the clinical trial?
Stanford UniversityOTHER
2,471 Previous Clinical Trials
17,501,742 Total Patients Enrolled
Synergic Medical Technologies, Inc.Lead Sponsor
2 Previous Clinical Trials
60 Total Patients Enrolled
Peter Tass, MD PhDPrincipal InvestigatorStanford University
Share this study with friends
Copy Link
Messenger